Breast Cancer News and Research

Latest Breast Cancer News and Research

Advanced breast cancer drug appears effective on multiple targets

An experimental breast cancer drug that simultaneously attacks five tumor targets has halted progression of the disease in a clinical trial for patients with advanced disease.

18 May 2005

Breast cancer chemotherapy regimen associated with life-threatening complications

The chemotherapy regimen of doxorubicin plus docetaxel, used to treat breast cancer in a clinical trial, was associated with an increased risk of serious complications, resulting in the premature termination of the trial, according to a study in the May 18 issue of JAMA.

17 May 2005

Doxorubicin-docetaxel combination is associated with an increased risk of severe and life-threatening complications

Researchers in France say a study using two chemotherapy agents to treat breast cancer was halted after two women in the study died.

17 May 2005

Postmenopausal women who follow a low-fat diet have 24 percent less chance of a recurrence of breast cancer

The study by Rowan T. Chlebowski and colleagues at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, involved 2,437 women aged 48 to 79 who were diagnosed with early stage breast cancer and were treated at several medical centers. All the women had the standard treatments such as surgery, radiation therapy, and chemotherapy and or tamoxifen therapy.

17 May 2005

Unlucky news for Kylie Minogue

The 36-year-old Australian Pop Diva was diagnosed with breast cancer while visiting her family at home in Melbourne, her management confirmed.

17 May 2005

New drug combination prevents breast cancer growth pre-surgery

A new type of drug originally developed for lung cancer can reduce the size of breast cancer tumours when taken in combination with other drugs.

17 May 2005

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Giving women with early breast cancer a drug called gefitinib (Iressa) before surgery could reduce the size of their tumours, suggests a randomised trial published online today by The Lancet Oncology.

17 May 2005

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Currently, breast cancer patients undergo axillary lymph node dissection for accurate staging and control of the cancer. In many cases, this major procedure can be replaced by sentinel lymph node biopsy, which is a more simple and less invasive surgical procedure, but many still have to undergo axillary dissection after the sentinel lymph node biopsy.

17 May 2005

Antibody combined with cancer drug shows promise against breast tumors

An antibody that targets the blood vessels nourishing tumors significantly reduced breast cancer formation and growth in mice when combined with a current cancer drug, according to researchers at UT Southwestern Medical Center.

16 May 2005

Combined MRI and mammography more effective at detecting breast cancer in high risk women

Annual screening, using magnetic resonance imaging (MRI) and X-ray mammography, is the best way to detect breast cancer in women that have a high genetic risk of the disease, according to a study published online by The Lancet.

16 May 2005

Statins appear to lessen chance of developing breast cancer

According to a new study women who are taking the cholesterol-lowering drugs called statins, such as Lipitor or Mevacor, appear to have much less chance of developing breast cancer.

16 May 2005

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

A targeted cancer drug given with low-dose chemotherapy shrank ovarian tumors and slowed progression of ovarian cancer in patients with recurrent disease, according to research findings presented by Agustin Garcia, M.D., principal investigator of the study and Director of Breast Cancer Research at the Women's Cancer Research Institute at the Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center.

16 May 2005

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.

16 May 2005

Moderate recreational and work-related physical activity may reduce the risk of ovarian cancer

While the benefits of physical activity in reducing colon and breast cancer are well established, results of studies on exercise and ovarian cancer have been inconclusive. Because ovarian cancer has such a poor prognosis, it is even more important to identify modifiable lifestyle factors that could prevent it.

16 May 2005

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

A Mayo Clinic-led study has revealed a genetic biomarker that can predict which patients are most likely to experience unwanted side effects from one of the most commonly used and highly effective chemotherapy regimens designed to treat colorectal cancer.

16 May 2005

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Final results from the largest international study in the treatment of advanced stomach cancer, also known as gastric cancer, demonstrated that patients who received a Taxotere (docetaxel) Injection Concentrate-based chemotherapy regimen (Taxotere, cisplatin and 5-fluorouracil) had significantly improved overall survival rates compared to patients who received a standard treatment (cisplatin and 5- fluorouracil).

16 May 2005

Zometa reduces bone loss in patients receiving breast cancer treatment

Data presented at the American Society of Clinical Oncology (ASCO) annual meeting in Orlando, Florida, demonstrate that Zometa (zoledronic acid), an intravenous bisphosphonate, was shown to inhibit bone loss in postmenopausal women treated with Femara (letrozole) in the adjuvant breast cancer setting (directly following surgery to prevent cancer recurrence).

16 May 2005

Breast cancer hormone drug might help prevent prostate cancer

A hormonal drug used to fight breast cancer might help prevent abnormal prostate growths from turning into cancers.

15 May 2005

Tamoxifen study counters hopes that drug might protect the heart

Despite previous studies hinting at tamoxifen's potential benefit for breast cancer survivors' heart health, California researchers have found that the breast cancer drug does not decrease survivors' risk of heart attack.

15 May 2005

Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer

Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer, particularly if their cancer is fueled by the hormones estrogen or progesterone, according to a data analysis by researchers at Boston's Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Harvard School of Public Health.

15 May 2005

Breast Cancer News and Research

Latest Breast Cancer News and Research

Advanced breast cancer drug appears effective on multiple targets

Breast cancer chemotherapy regimen associated with life-threatening complications

Doxorubicin-docetaxel combination is associated with an increased risk of severe and life-threatening complications

Postmenopausal women who follow a low-fat diet have 24 percent less chance of a recurrence of breast cancer

Unlucky news for Kylie Minogue

New drug combination prevents breast cancer growth pre-surgery

Gefitinib (Iressa) could reduce the size of breast cancer tumours

Patients with suspicious axillary lymph nodes in their breasts should first undergo ultrasound-guided fine-needle aspiration to avoid unnecessary surgery

Antibody combined with cancer drug shows promise against breast tumors

Combined MRI and mammography more effective at detecting breast cancer in high risk women

Statins appear to lessen chance of developing breast cancer

Bevacizumab (Avastin) combined with low-dose chemotherapy slows ovarian cancer

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Moderate recreational and work-related physical activity may reduce the risk of ovarian cancer

Genetic biomarker that may improve quality of life during treatment for colorectal cancer

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Zometa reduces bone loss in patients receiving breast cancer treatment

Breast cancer hormone drug might help prevent prostate cancer

Tamoxifen study counters hopes that drug might protect the heart

Postmenopausal women who consume even moderate amounts of alcohol may face an increased risk of breast cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Breast Cancer News and Research

Latest Breast Cancer News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in